繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

TC BioPharm Regains Compliance With Nasdaq Listing Rules

2024-08-16 01:42

01:42 PM EDT, 08/15/2024 (MT Newswires) -- TC BioPharm (TCBP) claimed Thursday it regained compliance with Nasdaq's minimum stockholders' equity requirement for continued listing of its American depositary shares.

The company believes it became compliant with the listing rules after closing certain transactions.

The bourse had approved Aug. 1, the biotech company's request to keep its listing if it met the requirement by Thursday.

Price: 3.43, Change: +0.10, Percent Change: +3.00

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。